Companies Dominating the Nucleic Acid Isolation and Purification Landscape
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The companies involved in the nucleic acid isolation and purification market are emphasizing numerous tactical strategies to strengthen their position in the global market landscape. The market is highly consolidated with intensifying competition between the key players. Companies such as Thermo Fisher, Qiagen, and Roche are dominating with a huge 52% of the global share. Besides this, leading firms are undertaking specifications such as automation, expansion in developing nations, and NGS integration to enhance their workflow. Furthermore, mergers and acquisitions, along with supportive regulatory frameworks, also boost healthy competition among the players.
Below is the list of a few prominent players in the industry:
|
Company Name |
Country |
Market Share |
|
Thermo Fisher Scientific |
USA |
23% |
|
Qiagen |
Germany |
20% |
|
Roche Diagnostics |
Switzerland |
14% |
|
Illumina |
USA |
10% |
|
Danaher |
USA |
9% |
|
Agilent Technologies |
USA |
xx% |
|
Merck KGaA |
Germany |
xx% |
|
Bio-Rad Laboratories |
USA |
xx% |
|
Takara Bio |
Japan |
xx% |
|
BGI Genomics |
China |
xx% |
|
Promega |
USA |
xx% |
|
New England Biolabs |
USA |
xx% |
|
F. Hoffmann-La Roche |
Switzerland |
xx% |
|
PerkinElmer |
USA |
xx% |
|
LGC Biosearch Technologies |
UK |
xx% |
|
Macherey-Nagel |
Germany |
xx% |
|
Zymo Research |
USA |
xx% |
|
BioMerieux |
France |
xx% |
|
Seegene |
South Korea |
xx% |
|
Medigen Biotech |
Taiwan |
xx% |
Below are the areas covered for each company under the top 15 global manufacturers: